Skip to main navigation Skip to search Skip to main content

TARGET-DERM: A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions

Project: Research

Project Details

StatusActive
Effective start/end date07/31/19 → 07/31/26

Funding

  • TARGET PharmaSolutions Inc: $52,025.40